The story of Sildenafil presents a interesting case for stakeholders in the drug sector. While initially a tremendous success, generating billions, the patent end and the subsequent flood of off-brand versions have https://knockoff750827.blogolize.com/sildenafil-and-pharma-a-speculative-investment-80946133